Please login to the form below

Not currently logged in
Email:
Password:

Consilium Strategic Communications appoints Chris Gardner

Former life sciences leader at Citigate Dewe Rogerson joins as partner

Chris GardnerHealthcare comms firm Consilium Strategic Communications has appointed Chris Gardner as a new partner.

Gardner has more than 15 years' experience in strategic communications from across the healthcare sector and has worked with companies at all stages of development including for some of the world's leading pharma and biotech companies. 

He has led communications strategies on multiple cross-border IPOs, private fundraisings and international M&A. 

His corporate communication experience includes profile-raising campaigns to support companies' business objectives and crisis communication.

Gardner was formerly a director in the life sciences team at Citigate Dewe Rogerson, where he worked from 2003 to 2015, and an associate director at former specialist bioscience communications consultancy, HCC De Facto. 

Mary-Jane Elliott, managing partner of Consilium Strategic Communications, said: “We are pleased to welcome Chris to the growing team at Consilium and are excited to bring someone of his seniority to the firm. Chris has significant experience which complements our world-leading strategic healthcare communications offering.”

16th July 2015

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...
Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...

Infographics